Ani Pharmaceuticals (ANIP) Cash from Operations (QoQ) (2010 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.92% |
| Mar 31, 2026 | 92.23% |
| Dec 31, 2025 | -31.07% |
| Sep 30, 2025 | -41.89% |
| Jun 30, 2025 | 116.66% |
| Mar 31, 2025 | 120.62% |
| Dec 31, 2024 | 27.14% |
| Sep 30, 2024 | -28.37% |
| Jun 30, 2024 | -4.68% |
| Mar 31, 2024 | -59.17% |
| Dec 31, 2023 | 39.08% |
| Sep 30, 2023 | 55.96% |
| Jun 30, 2023 | -3.72% |
| Mar 31, 2023 | 586.91% |
| Dec 31, 2022 | -221.45% |
| Sep 30, 2022 | 131.55% |
| Jun 30, 2022 | 39.37% |
| Mar 31, 2022 | -55.45% |
| Dec 31, 2021 | -125.56% |
| Sep 30, 2021 | -2,341.49% |